retatrutide not working reddit for weight loss: Study shows 30% body weight loss People Are Already Taking This

My guest today is Dr

Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, et al

Eli Lilly and Company Novo Nordisk #Pharma #GLP1 #Biologics #PharmaSupplyChain #DrugSafety Biotech Executive, Thought Leader & Creator | Diagnostics Executive | Microfluidics & Immunoassay Innovation | FDA Strategy Led EUA 230055, EUA 240006 & 510(k) K240728 | Oncology, AIBiology & IVD Commercialization Eli Lilly and Company #Retatrutide Phase 3 #Breakthrough: #Triple #Agonist (GLP-1/GIP/Glucagon) Driving Fat Burn, Appetite Control & Glucose Regulation Shows Up to 2.0% A1C Reduction + ~17% Weight Loss A major milestone in cardiometabolic innovation: Eli Lilly and Companys #retatrutide (GIP + GLP-1 + glucagon triple agonist) delivers best-in-class efficacy signals in Phase 3 (TRANSCEND-T2D-1) Key results (40 weeks) 1 Glycemic control A1C reduction: -1.7% to -2.0% vs placebo: -0.8% 2 Weight loss Up to -16.8% (~36.6 lbs) No plateau weight loss still ongoing 3 Cardiometabolic benefits Improvements in lipids, triglycerides, and blood pressure Key voice: Kenneth Custer Ph.D

Because Ipamorelin does not meaningfully spike cortisol or prolactin at documented research doses, the protocol tends to emphasize pulse timing (getting the GH burst to land at a useful moment, such as during early sleep) rather than aggressive dose escalation